UC-San Diego: How Well Do COVID-19 Vaccines Work Over the Longer Term?
April 02, 2021
April 02, 2021
LA JOLLA, California, April 2 (TNSJou) -- The University of California San Diego campus issued the following news:
COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death. In that sense, all of the currently approved vaccines -- Moderna, Pfizer and Johnson & Johnson -- have proven comparably effective.
But much less is known about the actual ability of these vacc . . .
COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death. In that sense, all of the currently approved vaccines -- Moderna, Pfizer and Johnson & Johnson -- have proven comparably effective.
But much less is known about the actual ability of these vacc . . .